AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: AstraZeneca / Prilosec (prilosec.com)
This is a non-functioning digital placeholder that fails to substantiate its brand identity or provide any medical substance. The extreme disconnect between the schema data and the live URL suggests a state of technical abandonment. It is a substance-free void that offers zero utility to healthcare consumers or professionals.
Restore the full homepage content immediately to provide the expected regulatory and product information for a global pharmaceutical brand. Correct the WebSite schema to match the prilosec.com domain and include proper sameAs links to official AstraZeneca corporate profiles. Implement a clear heading hierarchy starting with a descriptive H1 that defines the therapeutic area of the product. Add specific clinical proof links and regulatory status indicators to the footer to satisfy industry-specific proof expectations.
The substance ratio is effectively zero as the body text is composed entirely of error strings such as Resource Not Found and We are sorry. There are no clinical metrics, product specifications, or technical protocols to analyze; the only noun is AstraZeneca Medicines in the H2, but it lacks any supporting data. The site provides zero instances of specific evidence or named outcomes, earning a maximum penalty for specificity absence. The heading fluff is technically low because there are no power words, but the meta title 404 represents a total failure of informational signaling.
When multiple URL variants exist, AI generates multiple embeddings of the same page. Run a Canonical Identity Stability Audit to see whether your site resolves into a single authoritative version.
There is a total failure in signal-substance alignment because the primary signal of the homepage is a technical dead end. The metadata shows a title of 404, which contradicts the expected authoritative pharmaceutical landing page for a brand like Prilosec. Furthermore, the schema_json identifies the site as Multibrand with a URL of azpicentral.com, while the actual crawled URL is prilosec.com. This disconnect between the identity in the structured data and the domain name constitutes a severe case of semantic drift.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
The review_count and proof_links_count are both 0, indicating a complete lack of external validation across the provided data. While there are no fake reviews or trust theatre flags present, there is also no attempt to provide a path to clinical proof, GMP compliance, or regulatory status. The site is a vacuum of trust signals, offering no verification for the AstraZeneca brand entity mentioned in the heading structure.
The proof density is zero, as there are no claims to prove and no evidence provided in the clean_text. There are zero specific proof points, zero clinical trial citations, and zero regulatory clearance numbers such as FDA 510(k) or CE marks. The site is characterized by an absolute absence of the proof expectations defined in the industry dictionary, failing to provide even a basic indication for use.
To evaluate URL identity stability and multilingual coherence, review the Yoast Identity Stability audit. View the Yoast Identity Stability Audit for a practical example of canonical alignment and language layer integrity.
The content is a pure commodity template for a server error, matching the Resource Not Found pattern found across millions of broken web pages. The value proposition is non-existent, and the copy could be pasted onto any server in any industry without changing its meaning. Template language is dominant, as the standard pharmaceutical blocks like Pipeline or Clinical Data are replaced by generic error prompts. There is no unique positioning or science-driven solution visible in the 203 characters of available text.
There is a severe authority gap where the schema_json claims the entity is Multibrand at azpicentral.com, failing to match the Prilosec domain name. No experts, medical professionals, or researchers are named, leaving the brand without a verifiable digital footprint or technical authority. The technical credibility is further undermined by a broken heading hierarchy, which features an H2 tag without a preceding H1 tag to establish the page’s primary topic.
The site fails to demonstrate even basic technical or professional competence, which is a major disconnect for a brand associated with AstraZeneca Medicines. There are zero performance claims regarding efficacy, safety, or patient outcomes because the page content has vanished into a 404 state. The marketing tone is entirely replaced by technical error text, providing the ultimate proof of a performance gap between brand expectation and digital reality.
Medical Devices, Pharma & Biotech BS: AstraZeneca / Prilosec (prilosec.com)
The site text mentions AstraZeneca Medicines in an H2 tag, which aligns with the Pharma and Biotech industry classification. However, the presence of a Resource Not Found message prevents any verification of therapeutic areas, pharmacovigilance, or clinical trial data.
Before embeddings, before entities, before retrieval — the crawler must reach the text. Open the Crawlability & Indexation Guide to learn how access failures erase meaning long before interpretation begins.
“The BS score of 58 is driven by technical failure and identity drift rather than traditional marketing fluff. The lack of substantive content and the mismatch between the schema identity and the domain name create a site that fails to prove its own brand signal. The total absence of proof paths and the broken heading hierarchy contribute to a high score despite the lack of typical industry clichés.”
Analysis Disclosure & Source Attribution
Snapshot Date: June 19, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at AstraZeneca / Prilosec to view the most current version of their content and see directly what the company offers.